跳至主要内容
临床试验/PACTR202210816121866
PACTR202210816121866尚未招募2 期

Herbal preparation for the treatment of COVID-19: Randomized clinical trial to test the safety and efficacy on the viral clearance of SARS-CoV-2

Faculty of Pharmacy0 个研究点目标入组 120 人开始时间: 2022年10月26日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • Presence of SARS-CoV-2
  • Respiratory rate (RR) 10-30/min PaO2/FiO2 > 300 mmHg
  • SatO2 >95% in AA
  • No organ failure

排除标准

  • Patients who did not have a follow-up laboratory test
  • Patients with symptoms classified as severe to critical,
  • Patients with hepatic, renal
  • and/or hematological laboratory disturbances
  • hematological disturbances.
  • Severe case at least one of the following signs Respiratory rate (RR) > 30/min ;
  • SatO2 <93% in AA
  • PaO2/FiO2 < 300 mmHg
  • No organ failure Critical at least one of the signs Respiratory distress requiring mechanical ventilation Multi-organ failure Shock

研究者

发起方
Faculty of Pharmacy

相似试验